Hanley David C. 4
4 · Nuvation Bio Inc. · Filed Nov 21, 2025
Insider Transaction Report
Form 4
Hanley David C.
CHIEF TECHNICAL OPERATIONS
Transactions
- Exercise/Conversion
Class A Common Stock
2025-11-19$1.87/sh+200,000$374,000→ 224,000 total - Sale
Class A Common Stock
2025-11-19$7.14/sh−200,000$1,427,680→ 24,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-19−200,000→ 300,000 totalExercise: $1.87Exp: 2034-02-27→ Class A Common Stock (200,000 underlying)
Footnotes (3)
- [F1]Includes 3,000 shares acquired on each of May 19, 2025 and November 19, 2025 under the Issuer's 2021 Employee Stock Purchase Plan.
- [F2]Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.045 to $7.260. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F3]Option vests as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.